1.13
-0.02(-1.74%)
Currency In USD
| Previous Close | 1.15 |
| Open | 1.17 |
| Day High | 1.17 |
| Day Low | 1.12 |
| 52-Week High | 2.5 |
| 52-Week Low | 0.98 |
| Volume | 1,143 |
| Average Volume | 45,675 |
| Market Cap | 10.03M |
| PE | -0.77 |
| EPS | -1.46 |
| Moving Average 50 Days | 1.14 |
| Moving Average 200 Days | 1.48 |
| Change | -0.02 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.08 as of February 03, 2026 at a share price of $1.13. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $26.4 as of February 03, 2026 at a share price of $1.13.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
GlobeNewswire Inc.
Nov 17, 2025 12:00 PM GMT
MELVILLE, N.Y., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire Inc.
Nov 12, 2025 9:05 PM GMT
MELVILLE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financia
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
GlobeNewswire Inc.
Nov 05, 2025 9:30 PM GMT
MELVILLE, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it